Literature DB >> 11825732

Impact of junctional ectopic tachycardia on postoperative morbidity following repair of congenital heart defects.

A Dodge-Khatami1, O I Miller, R H Anderson, J M Gil-Jaurena, A P Goldman, M R de Leval.   

Abstract

OBJECTIVE: To determine the incidence of postoperative junctional ectopic tachycardia (JET), we reviewed 343 consecutive patients undergoing surgery between 1997 and 1999. The impact of this arrhythmia on in-hospital morbidity and our protocol for treatment were assessed.
METHODS: We reviewed the postoperative course of patients undergoing surgery for ventricular septal defect (VSD; n=161), tetralogy of Fallot (TOF; n=114), atrioventricular septal defect (AVSD; n=58) and common arterial trunk (n=10). All patients with JET received treatment, in a stepwise manner, beginning with surface cooling, continuous intravenous amiodarone, and/or atrial pacing if the haemodynamics proved unstable. A linear regression model assessed the effect of these treatments upon hours of mechanical ventilation, and stay on the cardiac intensive care unit (CICU).
RESULTS: Overall mortality was 2.9% (n=10), with three of these patients having JET and TOF. JET occurred in 37 patients (10.8%), most frequently after TOF repair (21.9%), followed by AVSD (10.3%), VSD (3.7%), and with no occurrence after repair of common arterial trunk. Mean ventilation time increased from 83 to 187 h amongst patients without and with JET patients (P<0.0001). Accordingly, CICU stay increased from 107 to 210 h when JET occurred (P<0.0001). Surface cooling was associated with a prolongation of ventilation and CICU stay, by 74 and 81 h, respectively (P<0.02; P<0.02). Amiodarone prolonged ventilation and CICU stay, respectively, by 274 and 275 h (P<0.05; P<0.06).
CONCLUSIONS: Postoperative JET adds considerably to morbidity after congenital cardiac surgery, and is particularly frequent after TOF repair. Aggressive treatment with cooling and/or amiodarone is mandatory, but correlates with increased mechanical ventilation time and CICU stay. Better understanding of the mechanism underlying JET is required to achieve prevention, faster arrhythmic conversion, and reduction of associated in-hospital morbidity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11825732     DOI: 10.1016/s1010-7940(01)01089-2

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  30 in total

1.  Part 10: Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.

Authors:  Monica E Kleinman; Allan R de Caen; Leon Chameides; Dianne L Atkins; Robert A Berg; Marc D Berg; Farhan Bhanji; Dominique Biarent; Robert Bingham; Ashraf H Coovadia; Mary Fran Hazinski; Robert W Hickey; Vinay M Nadkarni; Amelia G Reis; Antonio Rodriguez-Nunez; James Tibballs; Arno L Zaritsky; David Zideman
Journal:  Circulation       Date:  2010-10-19       Impact factor: 29.690

2.  Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations.

Authors:  Monica E Kleinman; Allan R de Caen; Leon Chameides; Dianne L Atkins; Robert A Berg; Marc D Berg; Farhan Bhanji; Dominique Biarent; Robert Bingham; Ashraf H Coovadia; Mary Fran Hazinski; Robert W Hickey; Vinay M Nadkarni; Amelia G Reis; Antonio Rodriguez-Nunez; James Tibballs; Arno L Zaritsky; David Zideman
Journal:  Pediatrics       Date:  2010-10-18       Impact factor: 7.124

3.  Association between perioperative dexmedetomidine and arrhythmias after surgery for congenital heart disease.

Authors:  Jacqueline M Shuplock; Andrew H Smith; Jill Owen; Sara L Van Driest; Matt Marshall; Benjamin Saville; Meng Xu; Andrew E Radbill; Frank A Fish; Prince J Kannankeril
Journal:  Circ Arrhythm Electrophysiol       Date:  2015-04-15

4.  A prospective analysis of the incidence and risk factors associated with junctional ectopic tachycardia following surgery for congenital heart disease.

Authors:  A S Batra; D S Chun; T R Johnson; E M Maldonado; B A Kashyap; J Maiers; C L Lindblade; M Rodefeld; J W Brown; J E Hubbard
Journal:  Pediatr Cardiol       Date:  2006 Jan-Feb       Impact factor: 1.655

5.  Management of postoperative junctional ectopic tachycardia in pediatric patients: a survey of 30 centers in Germany, Austria, and Switzerland.

Authors:  Andreas Entenmann; Miriam Michel; Ulrike Herberg; Nikolaus Haas; Matthias Kumpf; Matthias Gass; Friedemann Egender; Roman Gebauer
Journal:  Eur J Pediatr       Date:  2017-07-21       Impact factor: 3.183

6.  A genetic contribution to risk for postoperative junctional ectopic tachycardia in children undergoing surgery for congenital heart disease.

Authors:  Kristie Y Borgman; Andrew H Smith; Jill P Owen; Frank A Fish; Prince J Kannankeril
Journal:  Heart Rhythm       Date:  2011-07-06       Impact factor: 6.343

7.  Late occurrence of adenosine-sensitive focal junctional tachycardia in complex congenital heart disease.

Authors:  Eun-Jung Bae; Chung-Il Noh; Jung-Yun Choi; Yong-Soo Yun; Woong-Han Kim; Jeong-Ryul Lee; Yong-Jin Kim
Journal:  J Interv Card Electrophysiol       Date:  2005-03       Impact factor: 1.900

8.  Magnesium Lowers the Incidence of Postoperative Junctional Ectopic Tachycardia in Congenital Heart Surgical Patients: Is There a Relationship to Surgical Procedure Complexity?

Authors:  Dingchao He; Nathaniel Sznycer-Taub; Yao Cheng; Robert McCarter; Richard A Jonas; Sridhar Hanumanthaiah; Jeffrey P Moak
Journal:  Pediatr Cardiol       Date:  2015-03-12       Impact factor: 1.655

9.  Intravenous induction of therapeutic hypothermia in the management of junctional ectopic tachycardia: a pilot study.

Authors:  Brendan Patrick Kelly; Robert J Gajarski; Richard G Ohye; John R Charpie
Journal:  Pediatr Cardiol       Date:  2009-12-01       Impact factor: 1.655

10.  Management of postoperative pediatric cardiac arrhythmias: current state of the art.

Authors:  Jennifer N A Silva; George Van Hare
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.